Davita Inc vs Fabrinet — how do they compare? Davita Inc trades at $232 (market cap $15.12B), while Fabrinet trades at $485.31 (market cap $17.01B). The key difference: Davita Inc and Fabrinet are close in size by market cap, and Davita Inc is trading nearer its 52-week high, Fabrinet nearer its low. Which is the better fit depends on your goals.
| DVA | FN | |
|---|---|---|
Market Cap | $15.12B | $17.01B |
Sector | Health | Technology |
52-Week High | $235.71 | $746.47 |
52-Week Low | $103.87 | $277.04 |
Enterprise Value | $27.67B | $16.07B |
Trailing returns across standard periods
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →